# COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial

> **NCT04354155** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins All Children's Hospital** · enrollment: 40 (actual)

## Conditions studied

- Infection Viral
- Thromboses, Venous
- COVID-19

## Interventions

- **DRUG:** Enoxaparin Prefilled Syringe [Lovenox]

## Key facts

- **NCT ID:** NCT04354155
- **Lead sponsor:** Johns Hopkins All Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-02
- **Primary completion:** 2021-06-04
- **Final completion:** 2021-06-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04354155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04354155, "COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04354155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*